CompletedNCT00142948
Naltrexone with guanfacine to reduce heroin use
About this title
Read the official source — NCT00142948Medication studyAges 18–40RussiaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 40 years.
- Listed locations
- Saint PetersburgSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateFebruary 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 301
- Sponsor
- Baylor College of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Russia
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT00142948
- Official title
Show the full official title
Heroin Addiction Treatment: Naltrexone and Adrenergic Agents
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedSaint Petersburg, Russia · Russia
Questions about this study
Who is behind this study?
The study sponsor is Baylor College of Medicine, a university.
Did this study involve medication?
Yes. The study involved medication, including Naltrexone and Placebo.
Who was this study for?
Listed age limits: 18 years to 40 years.
